コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 LTBP and the LAP propeptides of TGF-beta (isoforms 1 and
2 LTBP-1 expression increased during the first 12 d in cul
3 LTBP-1 mRNA expression was reduced in slow-track (0.99 +
4 LTBP-1 was not detected in extracted beaded-string micro
5 LTBP-2 colocalized with tropoelastin within the perichon
6 LTBP-2 expression was not detected by in situ hybridizat
7 LTBPs and fibrillins are highly homologous molecules, an
8 orming growth factor beta-binding protein 1 (LTBP-1) targets latent complexes of transforming growth
9 identify latent TGF-beta binding protein 1 (LTBP-1), an extracellular matrix protein and key regulat
11 orming growth factor-beta-binding protein-1 (LTBP-1) belongs to a family of extracellular glycoprotei
13 s such as latent TGF-beta binding protein-1 (LTBP-1), decorin, biglycan, and fibromodulin can bind an
14 ibulin-4 (Fbln4) null cultures, fibrillin-1, LTBP-1, and LTBP-4 are incorporated into microfibrils.
15 ression reduced left atrial dimension (19%), LTBP-1 hydrolysis (40%), and collagen content (32%) when
16 th factor beta (TGF-beta) binding protein 2 (LTBP-2) is an integral component of elastin-containing m
18 orming growth factor-beta-binding protein-3 (LTBP-3) sequesters pro-myostatin in the extracellular ma
20 aVbeta6-mediated latent TGF-beta activation; LTBP-3 is unable to substitute for LTBP-1 in this assay.
23 trates that the binding sites for LTBP-1 and LTBP-4 are different and suggests that EGF3 may also con
26 d two TGF-beta1-binding proteins, LTBP-1 and LTBP-4; expression of the latter is necessary for secret
28 or by diminished sequestration of LTBP-3 and LTBP-4 into the fibrillin-1-deficient matrix of the oute
33 3; type I, II, and III receptors; as well as LTBP-1, decorin, and biglycan were up-regulated during a
34 rillins and their associated ligands such as LTBPs, fibulins, and EMILINs are of particular interest
35 e show that the covalent association between LTBP-1 and the extracellular matrix is transglutaminase
36 pite these differences, interactions between LTBP-1 and fibrillin-1 compete for interactions between
41 ll as by CARASIL mutations and disrupts both LTBP-1 binding to fibronectin and its incorporation into
42 1 knockout mice had increased levels of both LTBP-4 expression and TGF-beta activation, as well as en
43 ted the activation of TGF-beta1 presented by LTBPs but did not bind to TGF-beta1 presented by GARP or
44 gest that during differentiation of ES cells LTBP-1 facilitates endothelial cell organization via a T
47 fibrillin-1 (Fbn1) null fibroblast cultures, LTBP-1 and LTBP-4 are not incorporated into microfibrils
49 erved that a two-residue insertion in 8-Cys3(LTBP-1) increased the potential for disulfide exchange o
53 cated that enhanced binding of LAP to 8-Cys3(LTBP-4) is achieved if the residues A, S, and R are chan
54 sfected CHO cultures revealed that deltaN293 LTBP-1S was matrix associated via a transglutaminase-dep
58 of kidney fibrosis of different etiologies, LTBP-49247 attenuated fibrotic progression, indicating t
61 In tissues where LTBP-1 is not expressed, LTBP-4 may substitute for LTBP-1, because the C-terminal
63 The results reveal a functional role for LTBP-1 in latent TGF-beta activation and suggest that ac
64 her, these data identify a critical role for LTBP-4 in the regulation of latent TGF-beta1 activation
67 ated demonstrates that the binding sites for LTBP-1 and LTBP-4 are different and suggests that EGF3 m
69 is not expressed, LTBP-4 may substitute for LTBP-1, because the C-terminal end of LTBP-4 binds equal
70 Modelling of a homologous TB domain from LTBP-1 (residues 1018-1080) suggests that hydrophobic co
78 f TGF-beta by PSCs in vitro by investigating LTBP-1 organisation with fibrillar fibronectin and show
79 ins that includes three additional isoforms (LTBP-2, -3, and -4) and the matrix proteins fibrillin-1
80 e, we present evidence that MFS mice lacking LTBP-3 have improved survival, essentially no aneurysms,
81 though alphavbeta6 recognizes an RGD on LAP, LTBP-1 is required for alphaVbeta6-mediated latent TGF-b
82 rix is transglutaminase dependent, as little LTBP-1 is recovered from matrix digests prepared from cu
84 signaling caused by a lack of HtrA1-mediated LTBP-1 processing as mechanism underlying CARASIL pathog
85 odeling), a 60% increase in MT1-MMP-mediated LTBP-1 hydrolysis and a 190% increase in collagen conten
89 activate latent TGF-beta1 in the absence of LTBP, these mechanisms are not as efficient as those tha
92 These data suggest that the association of LTBP with the latent TGF-beta complex is important for p
94 tion of latent TGFbeta complexes composed of LTBP-3 and TGFbeta contributes to aortic disease progres
97 ression system, we have mapped the domain of LTBP-1 mediating covalent association with small latent
98 of LTBP-1S were used to identify domains of LTBP-1 involved in cross-linking and formation of TGF-be
101 ponse to bleomycin, but expression either of LTBP-4 lacking the TGF-beta-binding site or only the TGF
105 rylation of Smad2, and ectopic expression of LTBP-3 in mature mouse skeletal muscle increases fiber a
113 ll latent TGF-beta1 with deletion mutants of LTBP-1 showed that the third eight-cysteine repeat of LT
114 amino-terminal region of LTBP-1S, mutants of LTBP-1S with deletions of either the amino-terminal 293
117 y antibodies to the amino-terminal region of LTBP-1 block transglutaminase-dependent cross-linking of
118 domains within the amino-terminal region of LTBP-1S, mutants of LTBP-1S with deletions of either the
119 ibodies to the amino and carboxyl regions of LTBP-1S abrogate TGF-beta generation by vascular cell co
120 aining amino, middle, or carboxyl regions of LTBP-1S were used to identify domains of LTBP-1 involved
121 owed that the third eight-cysteine repeat of LTBP-1 is necessary and sufficient for covalent interact
126 To gain insight into the potential roles of LTBP in early development, we isolated the Xenopus LTBP-
127 We reported that a specific sequence of LTBP-1 is required for latent TGF-beta activation by the
128 accounted for by diminished sequestration of LTBP-3 and LTBP-4 into the fibrillin-1-deficient matrix
130 fibulins may affect matrix sequestration of LTBPs, because in vitro interactions between these prote
131 ted that LTBP-49247 recognized an epitope on LTBP-presented TGF-beta1 that is not accessible on GARP-
133 antibody, a TGF-beta receptor antagonist, or LTBP gene silencing results in the reversal of TGF-beta-
135 owth factors interact with fibrillins and/or LTBPs and are also targeted to the extracellular matrix.
137 the ability of PSCs to mechanically organise LTBP-1 and activate TGF-beta through a mechanism involvi
139 een LAP and latent TGF-beta-binding protein (LTBP) produces the most common form of latent TGF-beta,
141 sforming growth factor-beta binding protein (LTBP), which plays roles in targeting and activation, a
151 transforming growth factor-binding protein (LTBP-1) and activation of transforming growth factor-dep
152 ransforming growth factor-1 binding protein (LTBP-1), and MT1-MMP-specific LTBP-1 proteolytic activit
153 lly described as a TGF-beta-masking protein, LTBP-1 is involved both in the sequestration of latent T
155 forming growth factor-beta-binding proteins (LTBPs) are extracellular matrix (ECM) glycoproteins that
156 forming growth factor-beta-binding proteins (LTBPs) are extracellular matrix (ECM) glycoproteins that
157 ing growth factor B (TGFB)-binding proteins (LTBPs) are microfibril-associated proteins essential for
159 g growth factor (TGF)-beta binding proteins (LTBPs) modulate the secretion and activation of latent T
161 illins and latent TGF-beta-binding proteins (LTBPs) which are localized to fibrillar structures in th
162 he role of latent TGF-beta-binding proteins (LTBPs), key regulators of TGF-beta bioavailability and a
163 mulation of latent TGFbeta-binding proteins (LTBPs)-3 and -4, and reduced levels of phosphorylated (a
167 GF-beta1 and two TGF-beta1-binding proteins, LTBP-1 and LTBP-4; expression of the latter is necessary
170 t of fibroblasts with bleomycin up-regulated LTBP-4 mRNA, protein, and soluble LTBP-4-bound large lat
171 omycin-induced TGF-beta1 activation required LTBP-4, since lung fibroblasts deficient in LTBP-4 did n
172 -regulated LTBP-4 mRNA, protein, and soluble LTBP-4-bound large latent TGF-beta1 complexes in Thy-1 (
173 nding protein (LTBP-1), and MT1-MMP-specific LTBP-1 proteolytic activity was increased by 4-fold in t
174 ish the feasibility of selectively targeting LTBP-bound TGF-beta1 as an approach for treating fibrosi
178 ata were consistent with the hypothesis that LTBP-1 is a fibrillin-associated protein present in cert
180 other elastic fiber proteins, implying that LTBP-2 performs a yet undiscovered function in early dev
182 observations give support to the notion that LTBP-3 is important for the control of TGF-beta action.
183 The findings of this study suggest that LTBP-2 is an essential component for the formation of mi
184 beaded-string microfibrils, suggesting that LTBP-1 is not an integral structural component of microf
185 enotype related to glaucoma, suggesting that LTBP-2 deficiency primarily causes lens dislocation but
186 y determined DN protection and suggests that LTBP-1 may be involved in the pathogenesis of DN through
188 nct mechanisms that may be determined by the LTBP isoform and its potential interaction with the matr
190 binding site was within three domains of the LTBP-1 C terminus, and in fibrillin-1 the site was defin
193 Previous studies have revealed that the LTBP-LAP interaction is mediated by intracellular exchan
194 xons and shows a similar organization to the LTBP-2 gene, suggesting that these genes originated from
196 We previously generated mice in which the LTBP-binding cysteine residues in LAP TGF-beta1 were mut
198 d that inclusion of a polyclonal antibody to LTBP-1 during EB differentiation suppressed the expressi
200 ch the cysteines that link the propeptide to LTBP were mutated to serines, thereby blocking covalent